Companies

4D Molecular Therapeutics, Inc. (FDMT) SEC filings

CIK 0001650648 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)85.2 M20.7 M3.1 M
Net income (USD)-107.5 M-71.3 M
Diluted EPS (USD/shares)-2.42-2.58-3.32

Latest filings

FiledFormDescriptionPeriod
2026-10-20442026-10-16
2026-10-07442026-10-05
2026-10-05144144
2026-09-288-K8-K items 8.012026-09-28
2026-09-22442026-09-16
2026-09-16442026-09-14
2026-09-14144144
2026-09-03442026-09-01
2026-08-21442026-08-19
2026-08-19144144
2026-08-17442026-08-13
2026-08-17144144
2026-08-13144144
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.022026-08-13
2026-08-05442026-08-04
2026-08-04144144
2026-08-04442026-08-03
2026-08-03144144
2026-07-208-K8-K items 8.012026-07-18
2026-07-14442026-07-09
2026-07-10144144
2026-07-09144144
2026-07-02442026-06-30
2026-06-30144144

Forms on file (last 1,000): 4 142, 8-K 66, SC 13G/A 32, 144 30, 3 26, SCHEDULE 13G/A 18, 10-Q 17, SC 13G 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=FDMT (0.002 USD), /gw/filings/filings?ticker=FDMT&form=8-K, /gw/filings/facts?ticker=FDMT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange